Investing

Legend Biotech : LEGN

LEGN

Stock Data

$20.75

$1.47 (7.62%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Legend Biotech Corp is a pioneering biopharmaceutical company focused on creating innovative cell therapies for cancer and other serious diseases. With a leading product candidate aimed at treating multiple myeloma, Legend Biotech is at the forefront of developing chimeric antigen receptor (CAR) T-cell therapies. Their research spans a range of cancers, including leukemia, lymphoma, and various solid tumors. Founded in 2014 and headquartered in Somerset, New Jersey, the company collaborates with Janssen Biotech to advance the reach and effectiveness of its groundbreaking treatments.

Latest Activity

LEGNLegend Biotech Corporation

Reports Tue Aug 11Before open7:00 AM ETConfirmed

5:00am ET

Legend Biotech reports at 7:00 AM ET, and the only question that matters is whether Carvykti's growth is still outpacing J&J's Tecvayli with anito-cel's launch closing in. Manufacturing capacity commentary moves this $4 billion stock as much as the numbers do.

ShareRead more

All Legend Biotech Articles

3 Articles

Trey Thoelcke | Jun 24, 2026 at 7:55 AM EDT

After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching

Big Pharma's patent cliffs are forcing acquirers to hunt for revenue-producing biotech assets before rivals snap them up, and three…

Trey Thoelcke | May 14, 2026 at 9:20 AM EDT

Big Pharma’s 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs and hunt for…

Lee Jackson | Jan 22, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: Alphabet, Callaway Golf, Datadog, Hyatt Hotels, Palantir, Texas Instruments, Verizon, and More

Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back rally across the major indices on…